Cummins Strategy Partners
Strategic advisors to Pharma and Biotech for EU commercialisation
Why work with CSP
Senior led expertise
Every engagement led by an experienced European commercial executive with deep rare disease and speciality knowledge.
Early access & Evidence Specialists
Proven experience across European early access pathways and RWE strategies that support HTA and payer decisions.
Lean, Flexible Model
Fractional, project-based, or retained support aligned to biotech timelines and budgets.
Local Execution, Pan European view
Country level insight combined with a coherent EU wide strategy.
What we offer
European launch & Market Entry Strategy
Early commercial planning, country sequencing, pricing strategy and launch readiness.
Early Access and Evidence Strategy
Design and execution of Early Access Programmes and RWE strategies to support access, value, and transition to reimbursement.
Execution & Partner Enablement
Hands-on support cross regulatory , distribution, and market access partners- without building full in-country teams.